The new WHO-classification 2022
What remains? What is new?
The WHO book Haematolymphoid Tumours is now available as a Beta version:
MLL Munich Leukemia Laboratory
What we offer
Diagnostics
We are interdisciplinary experts. Our goal is to provide the best leukemia diagnostics for our patients by offering a comprehensive set of methods, state-of-the-art technology and continuous development.
Big Data
We empower physicians, biologists, scientists, and researchers with web-based tools that assist in variant interpretation of sequencing data in hematologic neoplasms.
Pharma
We have a wealth of experience supporting clinical research from clinical trial design to post-launch diagnostics.
Research
Through a large number of in-house scientific projects as well as national and international collaborations, we contribute to the improvement of leukemia and lymphoma diagnostics and risk stratification of patients.
Methods
Focused methods for leukemia diagnostics form the basis for a specific therapy.
Corporate film 2020
About us
News
Our MLLSEQ next generation sequencing service
We have launched the new label MLLSEQ
and outfitted it with its own logo
and a completely new Website.
You may also be interested in
Your contact person
»Patient wellbeing and digitalization are not a contradiction, but the future.«
Prof. Dr. med. Dr. phil. Torsten Haferlach
Executive management
Internist, Hematologist and Oncologist
Deputy Head of Cytomorphology
torsten.haferlach@mll.com